An autosomal dominant nonsyndromic deafness that has material basis in variation in the chromosome region 6p21.3.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
The documentation surrounding autosomal dominant nonsyndromic hearing loss 31 is limited due to its rarity and the recent identification of its genetic basis. With fewer cases reported globally, systematic clinical studies have been challenging, which contributes to the gaps in understanding the full clinical picture and associated phenotypes. Continued research efforts are crucial for better characterization and management of this condition.
To navigate your condition, consider consulting with an audiologist who specializes in genetic hearing loss. They can provide insights into hearing management strategies and potential future therapies. Additionally, genetic counseling may be beneficial to understand the implications of autosomal dominant inheritance for you and your family. While there are currently no patient organizations specifically for DFNA31, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov may offer valuable information and support.
Currently, there is one active clinical trial investigating autosomal dominant nonsyndromic hearing loss 31. Participating in clinical trials can provide access to new therapies and contribute to the understanding of this condition. For more information on the trial, you can visit the ClinicalTrials.gov search page at https://clinicaltrials.gov/search?cond=autosomal%20dominant%20nonsyndromic%20hearing%20loss%2031.
Actionable guidance for navigating care for autosomal dominant nonsyndromic hearing loss 31
To navigate your condition, consider consulting with an audiologist who specializes in genetic hearing loss. They can provide insights into hearing management strategies and potential future therapies. Additionally, genetic counseling may be beneficial to understand the implications of autosomal dominant inheritance for you and your family. While there are currently no patient organizations specifically for DFNA31, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov may offer valuable information and support.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.